Stoke Therapeutics Overview
Contact top employees from
Stoke Therapeutics
Summary
Stoke Therapeutics is a public company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Edward M. Kaye. Its headquarters is located at Bedford, Massachusetts, USA. The number of employees ranges from 25 to 100. The Stoke Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $272M. To connect with Stoke Therapeutics employee register on SignalHire.
Stoke Therapeutics industries
Biotechnology
Headquarters Location
Stoke Therapeutics Employees Size
100-200 employees
SIC Code
2836
DMA Code
Greater Boston
Founded
2017
Operating Status
Independent Company
Contact Stoke Therapeutics
Organization Website
Social Links
Phone Number
781-430-8200
Stoke Therapeutics Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2013 | Privately Held | 100 - 250 | 20.9M | $268.4M | |
| 2000 | Privately Held | 500 - 1.0K | 21.4M | $1.5B | |
| 2012 | Public Company | 100 - 250 | 15.7M | $227.8M | |
| 2008 | Privately Held | 25 - 100 | 2.2M | $160.5M | |
| 1987 | Public Company | 1 - 25 | < 1M | $1.3M | |
| 2006 | Privately Held | 25 - 100 | 1.2M | $230M | |
| 2008 | Public Company | 100 - 250 | 66.4M | $290.6M | |
| 2014 | Public Company | 100 - 250 | 132.2M | $267.1M | |
| 2007 | Public Company | 25 - 100 | 3.8M | $6.1M | |
| 2007 | Public Company | 25 - 100 | 15M | $210.9M | |
| 2010 | Public Company | 1.0K - 5.0K | 7B | $3.6B | |
| 2018 | Privately Held | 25 - 100 | 1.3M | $63M | |
| 2014 | Public Company | 1.0K - 5.0K | 80.4M | $1.2B | |
| 2003 | - | 1 - 25 | 4.6M | $32.2M | |
| 2008 | - | 25 - 100 | 3M | $48.2M | |
| 1999 | Public Company | 50K - 100K | 29.5B | $0 | |
| 1994 | Public Company | 50K - 100K | 45.6B | $0 | |
| 1848 | Public Company | 50K - 100K | 55.5B | $0 | |
| 2000 | Public Company | 500 - 1.0K | 15M | $0 | |
| 2011 | - | 25 - 100 | 5M | $0 | |
| 2007 | - | 200-500 | - | $- | |
| 1998 | - | 1000-5000 | - | $- | |
| 2002 | - | 1000-5000 | - | $- | |
| 2008 | - | 1000-5000 | - | $- | |
| 2004 | - | 500-1000 | - | $- | |
| 2008 | - | 100-200 | - | $- | |
| 2013 | - | 100-200 | - | $- | |
| - | - | 1000-5000 | - | $- |
Stoke Therapeutics Employees Turnover 2 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
1
Voyager Therapeutics, Inc.
3
Stoke Therapeutics
1
Lyndra Therapeutics
1
Mersana Therapeutics
1
Vanderbilt University
1
Amgen
Number of employees by department
Total number all of employee turnover
Ex-employees positions
In Company
In New Company
Contact top employees from
Stoke Therapeutics
Sharath Sasi
Principal Scientist, In Vitro Pharmacology
Brittany Youngs
Senior Scientist
Luis Alves
Associate Director, Clinical Supply Chain Management
Girija Raman PhD
Director Program Management
Steven Gross
Senior Medical Director, Clinical Development - Ophthalmology
Robert Santilli
Senior Manager, Clinical Business Operations
Brittney Thompson
Clinical Trial Management Consultant
Taylor McKenty
Clinical Trial Associate
Heather Abourjaily
Head of Medical Communications
Deirdre Slate
Scientist
Lori DuPree
Senior Director, Regional Medical Affairs
Anne Christiansen
Executive Director
Sue Devico
TMF Manager (Contract)
Arpita Patel
Director of Quality
Brian Werneburg
Global Medical Affairs | Rare Diseases
Malini Viswanathan PhD
Vice President Portfolio and Alliance Management
Barry Ticho MD
Chief Medical Officer
Asha Kadam
Principal Scientist
Chia Ching John Lin
Principal Scientist
Kelly Saluti
Director Clinical Operations
Eric Rojas
Vice President, Head of Investor Relations
Jessie Lynch
Senior Director, Pharmacovigilance
Geno Clemenzi
Executive Director, Regulatory Affairs
Daniel Ferreira
Senior Director, Regulatory CMC
Edward Kaye
CEO and Director
Sarfraz Shaikh
Senior Manager Quality Control
Jayen Diyora
Director, Manufacturing Validation
